National Comprehensive Cancer Network

|
|
|
|
For Patients

About NCCN

Ovarian Cancer Panel

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Ronald D. Alvarez, MD

None

Eli Lilly and Company;
GlaxoSmithKline;
Ortho Biotech Products, L.P.

None

None

9/28/2009

Deborah K. Armstrong, MD

None

Celgene Corporation;
Genentech, Inc.;
Agensys

None

None

7/17/2009

Barry Boston, MD

BEST

Bayer HealthCare;
Onyx Pharmaceuticals, Inc.;
Pfizer Inc.;
sanofi-aventis U.S.

None

None

10/28/2009

Robert Burger, MD, FACOG, FACS

       

Pending

Lee-may Chen, MD

AstraZeneca Pharmaceuticals LP

None

None

None

7/6/2009

Larry Copeland, MD

Eli Lilly and Company;
Genentech, Inc.;
Gynecologic Oncology Group

Bayer HealthCare;
Celgene Corporation;
Eli Lilly and Company;
Precision Therapeutics, Inc.;
sanofi-aventis U.S.

None

Gynecologic Oncology Group

10/2/2009

Marta Ann Crispens, MD

None

None

None

None

10/13/2009

Mary Dwyer Rosario, MS

None

None

None

None

7/1/2009

David K. Gaffney, MD, PhD

None

None

None

None

9/28/2009

Lauren Gallagher, PhD

None

None

None

None

8/28/2009

David M Gershenson, MD

AstraZeneca Pharmaceuticals LP;
Genentech, Inc.;
Johnson & Johnson;
National Cancer Institute

National Cancer Institute

Abbott Laboratories;
Amgen Inc.;
Eli Lilly and Company;
Johnson & Johnson;
Elsevier

None

9/28/2009

Benjamin E. Greer, MD

None

None

None

None

11/16/2009

Kristina M Gregory, RN, MSN, OCN

None

None

None

None

8/21/2009

Perry W. Grigsby, MD, MS, MBA

None

None

None

None

7/1/2009

Laura J. Havrilesky, MD

None

BD-TriPath Oncology;
Precision Therapeutics, Inc.

None

None

10/6/2009

Miranda Hughes, PhD

None

None

Myriad Genetic Laboratories, Inc.;
Affymetrix;
Qiagen NV

None

7/21/2009

Carolyn Johnston, MD

None

None

None

american cancer society-great lakes division;
michigan cancer consortium

7/8/2009

Johnathan M. Lancaster, MD, PhD

ImClone Systems Incorporated;
Merck & Co., Inc.;
Ortho Biotech Products, L.P.

Amgen Inc.;
Ortho Biotech Products, L.P.

None

None

9/29/2009

Shashikant Lele, MD

None

None

None

None

8/21/2009

Maurie Markman, MD

None

Amgen Inc.;
Boehringer Ingelheim GmbH;
Celgene Corporation;
Genentech, Inc.

None

None

7/16/2009

Ursula A. Matulonis, MD

AstraZeneca Pharmaceuticals LP;
Eli Lilly and Company;
Genentech, Inc.;
Merck & Co., Inc.

Eisai Inc.;
Merck & Co., Inc.

None

None

10/9/2009

Joan S McClure, MS

None

None

None

None

9/28/2009

Robert J. Morgan, MD, FACP

NIH-CTEP

None

Abbott Laboratories

None

7/1/2009

David M. O'Malley, MD

None

Eli Lilly and Company;
GlaxoSmithKline;
Ortho Biotech Products, L.P.

None

None

7/2/2009

Richard T. Penson, MD, MRCP

Berlex Inc.;
Eli Lilly and Company;
Genentech, Inc.;
ImClone Systems Incorporated;
CuraGen Corporation;
Dara BioSciences, Inc.;
Endocyte Inc.;
PDL BioPharma, Inc.

None

None

None

7/21/2009

Steven W. Remmenga, MD

None

None

None

None

9/28/2009

Paul Sabbatini, MD

None

Boehringer Ingelheim GmbH;
Genentech, Inc.;
Johnson & Johnson

None

None

9/1/2009

Russell J. Schilder, MD

None

None

None

None

7/2/2009

Julian C Schink, MD

None

None

None

None

9/28/2009

Nelson Teng, MD, PhD

GOG

None

None

None

11/16/2009

 

NCCN Website Supporters